XML 39 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 18 - Stock Option and Purchase Plans
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
(
18
)
Stock Option and Purchase Plans
 
The Company’s stock compensation program provides for the grant of restricted stock (including performance-based restricted stock), unrestricted stock, stock options and stock appreciation rights. A total of
3,655,088
shares of common stock were registered for issuance under the
2010
Omnibus Plan. On
May
19,
2015,
the
2010
Omnibus Plan was replaced with the
2015
Omnibus Plan. A total of
3,476,021
shares were registered for issuance under the
2015
Omnibus Plan. Additionally, awards under the
2010
Omnibus Plan that are cancelled without having been fully exercised or vested are available again for new awards under the
2015
Omnibus Plan. The aggregate number of shares available for future grant as of
December
 
31,
 
2016
and
2015
was
1,712,021
and
3,476,021,
respectively.
 
The
2010
and
2015
Omnibus Plans provide for restrictions which lapse after
three
years. During the restricted period, which is commensurate with each vesting period, the recipient has the right to receive dividends and voting rights for the shares. Generally, if a recipient leaves the Company before the end of the restricted period or if performance requirements, if any, are not met, the shares will be forfeited. During
2015,
the Company modified the restriction on certain restricted stock grants to increase the restriction period by
one
year. The modification did not have a material effect on the financial statements.
 
Under the plans, the Company
may
grant options to purchase common stock to officers, key employees and non-employee directors. Options
may
be granted at not less than the market price on the date of grant. Stock option grants under the
2010
and
2015
Omnibus Plans include a
five
year life along with vesting after
three
years of service.
 
Compensation expense is measured based on the fair value at the date of grant and is recognized on a straight-line basis over the vesting period. Fair value for restricted shares is equal to the stock price on the date of grant, while the fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing method. The Company uses historical Company and industry data to estimate the expected price volatility, the expected option life, the expected forfeiture rate and the expected dividend yield. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option.
 
The following weighted average assumptions were used to estimate the fair value of options granted using the Black-Scholes option-pricing model:
 
 
 
Year ended December 31,
 
 
 
2016
 
 
2015
 
Expected life (years)
   
4.0
     
4.0
 
Expected volatility
   
52.0
%    
50.2
%
Risk-free interest rates
   
1.42
%    
1.32
%
Expected dividend yield
   
0.0
%    
0.0
%
 
A summary of the restricted stock activity is as follows:
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
Average
 
 
 
Number of
 
 
Grant Date
 
 
 
Shares
 
 
Fair Value
 
Nonvested shares at January 1, 2016
   
1,074,700
    $
3.19
 
Granted
   
793,500
     
1.00
 
Vested
   
(609,200
)    
3.50
 
Forfeited
   
(94,000
)    
2.03
 
Nonvested shares at December 31, 2016
   
1,165,000
    $
1.49
 
 
The total fair value of shares vested during
2016
and
2015
was
$536,000
and
$230,000,
respectively. In conjunction with the vesting of restricted shares and payment of taxes thereon, the Company received into treasury
194,354
and
28,999
restricted shares, respectively, at an average price of
$0.98
and
$2.65
per share, respectively, the closing market price on the date the restricted stock vested. Such repurchased shares were immediately cancelled.
 
The following table summarizes option activity for the year ended
December
31,
2016:
 
 
 
 
 
 
 
Weighted-
 
 
Weighted-
 
 
 
 
 
 
 
 
 
 
 
average
 
 
average
 
 
Aggregate
 
 
 
Number of
 
 
Exercise Price
 
 
Remaining
 
 
Intrinsic
 
 
 
Shares
 
 
Per Share
 
 
Term
 
 
Value
 
Outstanding at January 1, 2016
   
1,222,000
    $
3.38
     
 
     
 
 
Granted
   
993,500
     
0.97
     
 
     
 
 
Exercised
   
0
     
0
     
 
     
 
 
Forfeited
   
(62,500
)    
1.95
     
 
     
 
 
Expired
   
(244,750
)    
4.14
     
 
     
 
 
Outstanding at December 31, 2016
   
1,908,250
    $
2.07
     
2.54
    $
0
 
Exercisable at December 31, 2016
   
561,550
    $
3.52
     
0.90
    $
0
 
      
The weighted average grant date fair value based on the Black-Scholes option pricing model for options granted in the years ended
December
 
31,
 
2016
and
2015
was
$0.38
and
$0.82
per share, respectively. There were
no
options exercised in
2016
or
2015.
 
As of
December
 
31,
 
2016,
there was
$1,163,000
of total unrecognized compensation cost, after estimated forfeitures, related to unvested share-based compensation granted under the plans. That cost is expected to be recognized over a weighted-average period of
1.2
years. The total fair value of option shares vested during the years ended
December
 
31,
 
2016
and
2015
was
not
material.